Free Trial
NASDAQ:ASTH

Astrana Health (ASTH) Stock Price, News & Analysis

Astrana Health logo
$24.29 -0.18 (-0.74%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$24.26 -0.02 (-0.10%)
As of 05/23/2025 06:09 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Astrana Health Stock (NASDAQ:ASTH)

Key Stats

Today's Range
$23.88
$24.61
50-Day Range
$24.29
$34.05
52-Week Range
$23.12
$63.20
Volume
254,478 shs
Average Volume
290,686 shs
Market Capitalization
$1.36 billion
P/E Ratio
18.68
Dividend Yield
N/A
Price Target
$53.29
Consensus Rating
Moderate Buy

Company Overview

Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.

Astrana Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
70th Percentile Overall Score

ASTH MarketRank™: 

Astrana Health scored higher than 70% of companies evaluated by MarketBeat, and ranked 278th out of 919 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Astrana Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 6 buy ratings, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Astrana Health has only been the subject of 4 research reports in the past 90 days.

  • Read more about Astrana Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Astrana Health are expected to grow by 22.61% in the coming year, from $1.15 to $1.41 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Astrana Health is 18.68, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 24.80.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Astrana Health is 18.68, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 26.72.

  • Price to Earnings Growth Ratio

    Astrana Health has a PEG Ratio of 1.37. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Astrana Health has a P/B Ratio of 2.30. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Astrana Health's valuation and earnings.
  • Percentage of Shares Shorted

    4.16% of the float of Astrana Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Astrana Health has a short interest ratio ("days to cover") of 4.9.
  • Change versus previous month

  • Dividend Yield

    Astrana Health does not currently pay a dividend.

  • Dividend Growth

    Astrana Health does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.16% of the float of Astrana Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Astrana Health has a short interest ratio ("days to cover") of 4.9.
  • Change versus previous month

  • News Sentiment

    Astrana Health has a news sentiment score of 1.14. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.73 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 9 news articles for Astrana Health this week, compared to 4 articles on an average week.
  • Search Interest

    Only 1 people have searched for ASTH on MarketBeat in the last 30 days. This is a decrease of -89% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Astrana Health insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    20.00% of the stock of Astrana Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    52.77% of the stock of Astrana Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Astrana Health's insider trading history.
Receive ASTH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Astrana Health and its competitors with MarketBeat's FREE daily newsletter.

ASTH Stock News Headlines

[INSIDE] Elon’s Next Move Could Send This AI Stock Soaring
Missed Nvidia? This Under-the-Radar AI Stock Could Be Next Musk's AI empire is just beginning — and one overlooked company could be at the center of it all. We reveal everything in this exclusive Memorial Day webinar.
See More Headlines

ASTH Stock Analysis - Frequently Asked Questions

Astrana Health's stock was trading at $31.53 at the beginning of 2025. Since then, ASTH shares have decreased by 23.0% and is now trading at $24.29.
View the best growth stocks for 2025 here
.

Astrana Health, Inc. (NASDAQ:ASTH) announced its earnings results on Thursday, May, 8th. The company reported $0.14 EPS for the quarter, missing analysts' consensus estimates of $0.23 by $0.09. The business's revenue was up 53.4% compared to the same quarter last year.
Read the conference call transcript
.

Astrana Health's top institutional shareholders include Vanguard Group Inc. (8.74%), SteelPeak Wealth LLC (1.13%), Charles Schwab Investment Management Inc. (0.89%) and Northern Trust Corp (0.82%).

Shares of ASTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Astrana Health investors own include Tesla (TSLA), JPMorgan Chase & Co. (JPM), NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Netflix (NFLX) and Visa (V).

Company Calendar

Last Earnings
5/08/2025
Today
5/23/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Management consulting services
Sub-Industry
Business Services
Current Symbol
NASDAQ:ASTH
Previous Symbol
NASDAQ:ASTH
Employees
1,900
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$53.29
High Stock Price Target
$70.00
Low Stock Price Target
$36.00
Potential Upside/Downside
+119.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
10 Analysts

Profitability

Trailing P/E Ratio
18.68
Forward P/E Ratio
21.12
P/E Growth
1.37
Net Income
$60.72 million
Pretax Margin
4.86%

Debt

Sales & Book Value

Annual Sales
$2.25 billion
Cash Flow
$0.93 per share
Price / Cash Flow
26.15
Book Value
$10.58 per share
Price / Book
2.30

Miscellaneous

Free Float
51,494,000
Market Cap
$1.36 billion
Optionable
Optionable
Beta
1.00
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

This page (NASDAQ:ASTH) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners